The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure

Archives of Gynecology and Obstetrics

Volumn 283, Issue 4, 2011, Pages 871-877

  Dogan, Nasuh Utku ^a,c   Salman, Mehmet Coskun ^b   Yuce, Kunter ^b  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Cervical intraepithelial neoplasia; LEEP; Persistent HPV infection

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; ELECTROSURGERY; FEMALE; FOLLOW UP; HPV DNA TESTING; HUMAN; HYSTERECTOMY; LOOP ELECTROSURGICAL EXCISION; PAPILLOMAVIRUS INFECTION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RECURRENT CANCER; TREATMENT FAILURE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRAL CLEARANCE; VIRUS EXAMINATION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ELECTROSURGERY; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 79955932949     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1530-1     Document Type: Article

References (38)

1. Cronje HS (2004) Screening for cervical cancer in developing countries. Int J Gynaecol Obstet 84(2):101-108
2. Walboomers JM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12-19 (Pubitemid 29406813)
3. Munoz N et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527 (Pubitemid 36159887)
4. Sellors JW et al (2000) Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 163(5):503-508
5. Monsonego J et al (2004) Cervical cancer control, priorities and new directions. Int J Cancer 108(3):329-333
6. Liaw KL et al (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183(1):8-15
7. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186-192
8. Cox JT, Schiffman M, Solomon D (2003) Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188(6):1406-1412 (Pubitemid 36741266)
9. Holowaty P et al (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91(3):252-258 (Pubitemid 29090994)
10. Falls RK (1999) Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol 181(2):278-282
11. Wright TC Jr et al (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197(4):346-355
12. Andersen ES, Thorup K, Larsen G (1988) The results of cryosurgery for cervical intraepithelial neoplasia. Gynecol Oncol 30(1):21-25
13. Chanen W, Rome RM (1983) Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey. Obstet Gynecol 61(6):673-679 (Pubitemid 13094616)
14. Burke L (1982) The use of the carbon dioxide laser in the therapy of cervical intraepithelial neoplasia. Am J Obstet Gynecol 144(3):337-340
15. Alonso I et al (2006) Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 103(2):631-636 (Pubitemid 44602179)
16. Tangtrakul S et al (2002) Detection of residual disease by cytology in patients with cervical intraepithelial neoplasia III post-large loop excision of the transformation zone. J Obstet Gynaecol Res 28(2):95-98 (Pubitemid 34732560)
17. Flannelly G et al (2001) Follow up after LLETZ: could schedules be modified according to risk of recurrence? BJOG 108(10):1025-1030
18. Verguts J et al (2006) Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 113(11):1303-1307 (Pubitemid 44581521)
19. Park JY et al (2009) Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. J Gynecol Oncol 20(2):86-90
20. Ribaldone R et al (2009) Role of HPV testing in the follow-up of women treated for cervical dysplasia. Arch Gynecol Obstet
21. Jeong NH et al (2009) High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. J Obstet Gynaecol Res 35(4):706-711
22. Paraskevaidis E et al (2004) The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 30(2):205-211 (Pubitemid 38418058)
23. Hernadi Z et al (2005) Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol 118(2):229-234 (Pubitemid 40093840)
24. Baloglu A et al (2009) Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Arch Gynecol Obstet
25. Kim YT et al (2010) Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer 126(8):1903-1909
26. Chan BK et al (2009) Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol 200(4):422.e1-422.e9
27. Zielinski GD et al (2003) HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 91(1):67-73 (Pubitemid 37188595)
28. Brismar S et al (2009) Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol 201(1):17.e1-17.e8
29. MacLean AB (1984) Cervical healing and Langerhans' cells. Br J Obstet Gynaecol 91(11):1145-1148
30. Ewies AA, Sant Cassia LJ (2000) A review of the treatment failures following cervical intraepithelial neoplasia grade III treated by large loop excision of the transformation zone. J Obstet Gynaecol 20(4):399-402 (Pubitemid 30621147)
31. Wright TC Jr et al (2007) 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 197(4):340-345
32. Lin CT et al (2001) Value of human papillomavirus deoxyribo-nucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 184(5):940-945
33. Paraskevaidis E et al (2003) Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 24(6):541-543 (Pubitemid 37462577)
34. Sarian LO et al (2004) HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 94(1):181-186 (Pubitemid 38950517)
35. Nobbenhuis MA et al (2001) Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84(6):796-801 (Pubitemid 32275653)
36. Coupe VM et al (2007) Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG 114(4):416-424 (Pubitemid 46393302)
37. Nam K et al (2009) Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 20(2):91-95 (epub 29 June 2009)
38. Bais AG et al (2009) Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease. Int J Cancer 124(4):889-895